Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $1.2300 (-5.02%) ($1.2300 - $1.2300) on Fri. Dec. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.18% (three month average) | RSI | 29 | Latest Price | $1.2300(-5.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -3.1% a day on average for past five trading days. | Weekly Trend | ANPC declines -13.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) TIP(14%) GLD(10%) VIXM(10%) UNG(9%) UUP(9%) | Factors Impacting ANPC price | ANPC will decline at least -3.09% in a week (0% probabilities). IFRA(-20%) XLP(-19%) SDY(-19%) SPLV(-17%) VYM(-16%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.09% (StdDev 6.18%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-20.78(-1789.43%) | Resistance Level | $1.57 | 5 Day Moving Average | $1.27(-3.15%) | 10 Day Moving Average | $1.43(-13.99%) | 20 Day Moving Average | $1.57(-21.66%) | To recent high | -64.7% | To recent low | 3.4% | Market Cap | $11m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |